News
Press release on our reports

Press release

Transparency of pharmaceutical sponsorship for patient initiatives increased significantly – May 2023
Austria has catching up to do in prevention and care of mental illness during and (in the first year) after pregnancy – April 2023
What has to be considered for osteopathic services in Austria – February 2023
How dementia quality registries can contribute to better dementia care – February 2023
Benefit of risk-based breast cancer screening is still unclear – October 2022
What telemedical care programmes can do for people with diabetes – July 2022
Prenatal diagnostics: Expectant parents should be able to make an informed decision – July 2022
About a quarter of children grow up with a mentally ill parent – April 2022
How Austrians can become healthier – February 2022
Digital health apps: Little evidence for benefits of "symptom checkers“ – December 2021
How long COVID patients should be cared for – November 2021
Extremely expensive medicines endanger solidarity-based health care system – September 2021
What is known about long COVID so far – August 2021
COVID-19 medication is still a long time coming – June 2021
Austrian Institute for Health Technology Assessment (AIHTA) presents Research Programme for 2021/22 – June 2021
Low transparency on pharmaceutical sponsorship for patient initiatives – May 2021
Austrian Institute for Health Technology Assessment (AIHTA): New Scientific Advisory Board – April 2021
Stroke rehabilitation: Technological support with robots and functional electrical stimulation put to test – April 2021
Home treatment: Good successes with psychiatric diseases in children & adolescents through home treatment – January 2021
Health-Apps on prescription? Health insurance providers lack consistent criteria to decide on the benefits and reimbursement of health apps – December 2020
Oncological end-of-life care shows: high care intensity, but less and late palliative care in Austria – September 2020
COVID-19: The pharmaceutical industry at a crossroads – Juni 2020
COVID-19: 155 drugs and 79 vaccines under development worldwide – April 2020